Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Editas Medicine, Inc

+1 (617) 401-9000
Website

Advertisement

Advertisement

300 3rd St Ste 1
Cambridge, MA 02142
+1 (617) 401-9000
https://www.editasmedicine.com

Editas Medicine, Inc. is a prominent gene editing company headquartered in Cambridge. Specializing in CRISPR technology, the company is dedicated to creating innovative medicines for individuals facing severe illnesses.

With a focus on developing CRISPR therapies, Editas Medicine aims to provide cutting-edge solutions for those with serious diseases. Their commitment to gene editing research positions them as a leader in the field of genetic medicine.

Generated from their website's infomation

Also at this address

Gollob, Jared A MD

UPS Drop Box

McGregor, Tracy Lynn MD

Beal Companies

Find related places

Contractors

Contractors

Own this business?
Claim it
See a problem?

You might also like

Nonresidential construction, nec, nec

Vaxess Technologies

Vaxess Technologies, based in Cambridge, MA, is dedicated to transforming access to vaccines and therapeutics through innovative biomedical solutions. Their team of diverse life scientists, engineers, and entrepreneurs is committed to developing groundbreaking technologies that improve human health worldwide. Utilizing the skin as a delivery pathway, Vaxess' mimix patch delivers bioactive compounds to the body, offering a unique approach to vaccine and therapeutic delivery. By combining immune activating biology with adaptive silk biomaterials, Vaxess is pioneering vaccines and therapeutics that stand out from existing technologies. Generated from the website
Nonresidential construction, nec, nec, Blood derivatives

Emulate Inc

Emulate Inc, based in Boston, MA, offers a cutting-edge platform for modeling the holistic journey of solid tumor cell therapy through organ chips. Their innovative technology allows researchers to simulate key processes such as vascular administration, endothelial attachment, T cell migration, and antigen-specific killing in a vascularized cancer cell line model. With a focus on reducing translational failure and improving human disease research, Emulate's human emulation system provides unparalleled insights into the inner workings of human biology. Their platform, comprised of instruments, consumables, and software, is user-friendly and flexible, offering researchers a powerful tool for advancing research and drug development in various fields such as cancer gene therapy, immunology, infectious disease, and neuroscience. Generated from the website
Nonresidential construction, nec, nec, Drugs and drug proprietaries

Cytosolve

CytoSolve, Inc. is a leading biotechnology company based in Cambridge, MA. They collaborate with renowned scientists and research institutions to develop large-scale systems architecture and models of disease and complex biological phenomena. Their innovative approach, known as the CytoSolve approach, aims to revolutionize the field of precision personalized medicine by using in silico mechanistic modeling to study phenomena that are not possible through traditional in vitro and in vivo experiments. Additionally, CytoSolve is involved in the development of functional food dietary supplements and cosmetics, with a focus on reducing toxicity and risk while providing effective and safe products.Generated from the website
United States›Massachusetts›Cambridge›Editas Medicine, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell